2025-07-10 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc (HIMS) based on the provided data. I'll present the key metrics, provide analysis, and then offer an overall summary.

**Hims & Hers Health Inc (HIMS) Analysis**

**Company Overview:** Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions.

**1. Performance vs. S&P 500 (VOO):**

*   **HIMS Cumulative Return:** 186.17%
*   **VOO Cumulative Return:** 63.51%
*   **Absolute Divergence:** 116.5 (HIMS outperformed VOO by this much)
*   **Relative Divergence:** 54.3 (HIMS's outperformance is positioned in the 54.3 percentile of its historical divergence range relative to VOO.)

**Analysis:**

*   HIMS has significantly outperformed the S&P 500 (VOO) over the analyzed period.
*   The relative divergence indicates that while HIMS has outperformed, there's room for it to move higher relative to its historical performance against VOO.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha  | Beta   | Cap(B) |
| :---------- | :----- | :----- | :----- | :----- | :----- |
| 2019-2021  | -46.0% | 51.0% | -84.0% | -0.0 | 1.5    |
| 2020-2022  | -15.0% | 72.1% | -17.0% | -0.0 | 1.4    |
| 2021-2023  | -51.0% | 72.1% | -69.0% | -0.1 | 2.0    |
| 2022-2024  | 127.0% | 78.4% | 101.0% | -0.1 | 5.4    |
| 2023-2025  | 181.0% | 78.4% | 134.0% | -0.1 | 11.3   |

**Analysis:**

*   **CAGR:** Shows a highly variable growth rate, with significant negative returns in earlier periods and very strong positive returns in the most recent periods.
*   **MDD (Maximum Drawdown):** Indicates substantial risk, with drawdowns exceeding 50% in some periods, although the company's recent CAGR is high, the MDD suggests caution due to potential volatility.
*   **Alpha:** Shows periods of significant underperformance relative to the market in the past, but strong outperformance in the recent periods.
*   **Beta:** is negative, indicating that HIMS moves inversely to the market but with a very low correlation.
*   **Cap (B):** Indicates that the company's market capitalization has grown significantly, particularly in the most recent periods.

**2. Recent Stock Price Movement:**

*   **Current Price:** 50.7
*   **Last Market Data:** Price: 50.695, Previous Close: 48.96, Change: 3.54 (Positive change)
*   **5-Day Moving Average:** 48.504
*   **20-Day Moving Average:** 52.0505
*   **60-Day Moving Average:** 47.4187

**Analysis:**

*   The current price is above the 5-day and 60-day moving averages, but below the 20-day moving average. This suggests a mixed short-term trend, potentially indicating a recent pullback or consolidation after a rally.
*   The positive change in the last market data (price increase from the previous close) indicates a recent positive movement.

**3. Technical Indicators & Expected Return:**

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 39.76 (Approaching oversold territory, but not quite there yet)
*   **PPO:** -0.814 (Below zero, indicating a possible downtrend, but relatively close to zero)
*   **Hybrid Signal:** cash_69%_Sell 1.9% of holdings (24 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** -0.7 (Short-term decline)
*   **Expected Return:** -17.3% (Long-term underperformance relative to S&P 500 if investing from the current point)

**Analysis:**

*   The MRI suggests low market risk.
*   The RSI suggests the stock is approaching oversold conditions, which *could* signal a potential buying opportunity, *but it's not a guarantee.*
*   The PPO indicates a slight downtrend, but it's not a strong signal.
*   The hybrid signal suggests a cautious approach, recommending a high cash position.
*   The negative expected return is a concern for long-term investors.

**4. Recent News & Significant Events:**

*   [2025-07-09] Major business developments, regulatory changes, or market events.
*   [2025-07-08] Analyst discussions on performance and outlook within industry trends and global economic factors.
*   [2025-07-10] Notable stock volatility due to news, earnings, or executive actions.
*   [2025-07-07] Market experts highlight both risks and opportunities, advising monitoring of news and announcements.

**Analysis:**

*   The news suggests the stock is experiencing volatility and is subject to external factors like regulatory changes and market events.
*   Analysts are actively discussing the company, indicating it's under scrutiny.
*   Investors should closely monitor news and company announcements.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
| :--------- | :--- | :--------- |
| 2025-05-05 | 0.22 | 0.59 B$    |
| 2024-11-04 | 0.35 | 0.40 B$    |
| 2024-08-05 | 0.06 | 0.32 B$    |
| 2024-05-06 | 0.05 | 0.28 B$    |
| 2025-05-05 | 0.05 | 0.28 B$    |

**Analysis:**

*   EPS has fluctuated, with the highest value in 2024-11-04 and decreasing to 0.05 by 2025-05-05.
*   Revenue has consistently increased over the analyzed quarters, indicating positive sales growth.
*   The latest earnings show a decrease in EPS despite a significant increase in revenue, suggesting potential margin pressures or increased operating expenses.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31   | $0.59B    | 73.50%        |
| 2024-12-31   | $0.48B    | 76.81%        |
| 2024-09-30   | $0.40B    | 79.16%        |
| 2024-06-30   | $0.32B    | 81.30%        |
| 2024-03-31   | $0.28B    | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
| :----------- | :-------- | :------- |
| 2025-03-31   | $0.55B    | 9.01%    |
| 2024-12-31   | $0.48B    | 5.46%    |
| 2024-09-30   | $0.44B    | 17.18%   |
| 2024-06-30   | $0.36B    | 3.67%    |
| 2024-03-31   | $0.34B    | 3.23%    |

**Analysis:**

*   **Revenue:** Shows consistent growth, indicating increasing sales.
*   **Profit Margin:** Decreasing, which could indicate higher costs or pricing pressures.
*   **Equity:** Growing, suggesting increasing assets and retained earnings.
*   **ROE (Return on Equity):** Fluctuates, showing varying efficiency in using equity to generate profits.  The drop in the most recent quarter is a concern.

**7. Overall Summary:**

Hims & Hers Health Inc. (HIMS) presents a mixed picture:

*   **Strengths:**
    *   Significant outperformance against the S&P 500 in the past.
    *   Consistent revenue growth.
    *   High growth rate in recent years, with a substantial increase in market capitalization.
*   **Weaknesses/Concerns:**
    *   Negative expected return based on current conditions.
    *   Declining profit margins and fluctuating ROE, which need further investigation.
    *   Recent short-term downtrend and analyst caution signals.
    *   High volatility and sensitivity to news events.
    *   In the past, showed substantial risk, with drawdowns exceeding 50% in some periods

**Recommendation:**

Given the mixed signals, a cautious approach is warranted. Investors should closely monitor upcoming earnings reports, news, and analyst commentary. The high volatility suggests this stock is better suited for investors with a higher risk tolerance and a shorter investment horizon or those who are comfortable actively managing their position.  Further research is needed to understand the reasons behind the declining profit margins and whether they are temporary or indicative of a longer-term trend.

